1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > B-Cell Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

B-Cell Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “B-Cell Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the B-Cell Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Hodgkin Lymphoma . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Hodgkin Lymphoma . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

B-Cell Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
B-Cell Hodgkin Lymphoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of B-Cell Hodgkin Lymphoma to Oncology Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Unaccomplished Trials of B-Cell Hodgkin Lymphoma 17
Subjects Recruited Over a Period of Time 18
Clinical Trials by Sponsor Type 19
Prominent Sponsors 20
Top Companies Participating in B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials 21
Prominent Drugs 22
Clinical Trial Profiles 23
Clinical Trial Overview of Top Companies 23
Teva Pharmaceutical Industries Limited 23
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 23
Incyte Corporation 24
Clinical Trial Overview of Incyte Corporation 24
Clinical Trial Overview of Top Institutes / Government 25
National Cancer Institute 25
Clinical Trial Overview of National Cancer Institute 25
Fred Hutchinson Cancer Research Center 26
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 26
German Hodgkin Study Group 27
Clinical Trial Overview of German Hodgkin Study Group 27
The University of Texas M. D. Anderson Cancer Center 28
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 28
Rutgers, The State University of New Jersey 29
Clinical Trial Overview of Rutgers, The State University of New Jersey 29
University of Nebraska 30
Clinical Trial Overview of University of Nebraska 30
Case Comprehensive Cancer Center 31
Clinical Trial Overview of Case Comprehensive Cancer Center 31
Five Key Clinical Profiles 32
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 107

List of Tables
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Countries, 2014* 9
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 10
Proportion of B-Cell Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 11
B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 12
B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 13
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014* 14
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 15
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 16
B-Cell Hodgkin Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2014* 17
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18
B-Cell Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 19
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 20
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 21
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 22
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014* 23
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2014* 24
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 25
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 26
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by German Hodgkin Study Group, 2014* 27
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 28
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014* 29
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014* 30
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014* 31

List of Figures
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 9
Proportion of B-Cell Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 11
B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 12
B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 13
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 14
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 15
B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 16
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 18
B-Cell Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 19
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 20
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 21
B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 22
GlobalData Methodology 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

Epiomic Epidemiology Series: Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hodgkin’s Lymphoma in 17 Major Markets Hodgkin’s Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma o ...

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market  Forecast-2023

Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Non-Hodgkin’s Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the ...

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.